Eleni Tzortzaki
Eleni Tzortzaki
Medical School, University of Crete
Verified email at
Cited by
Cited by
Few smokers develop COPD. Why?
NM Siafakas, EG Tzortzaki
Respiratory medicine 96 (8), 615-624, 2002
Apoptotic mechanisms in the pathogenesis of COPD
M Plataki, E Tzortzaki, P Rytila, M Demosthenes, A Koutsopoulos, ...
International journal of chronic obstructive pulmonary disease 1 (2), 161, 2006
Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease
NM Siafakas, KM Antoniou, EG Tzortzaki
International journal of chronic obstructive pulmonary disease 2 (4), 453, 2007
Microsatellite DNA instability in COPD
NM Siafakas, EG Tzortzaki, G Sourvinos, D Bouros, N Tzanakis, A Kafatos, ...
Chest 116 (1), 47-51, 1999
Long-term omalizumab treatment in severe allergic asthma: the South-Eastern Mediterranean “real-life” experience
EG Tzortzaki, A Georgiou, D Kampas, M Lemessios, M Markatos, ...
Pulmonary pharmacology & therapeutics 25 (1), 77-82, 2012
Oxidative DNA damage and somatic mutations: a link to the molecular pathogenesis of chronic inflammatory airway diseases
EG Tzortzaki, K Dimakou, E Neofytou, K Tsikritsaki, K Samara, M Avgousti, ...
Chest 141 (5), 1243-1250, 2012
A hypothesis for the initiation of COPD
EG Tzortzaki, NM Siafakas
European Respiratory Journal 34 (2), 310-315, 2009
DNA damage due to oxidative stress in chronic obstructive pulmonary disease (COPD)
E Neofytou, EG Tzortzaki, A Chatziantoniou, NM Siafakas
International journal of molecular sciences 13 (12), 16853-16864, 2012
Increased apoptosis of neutrophils in induced sputum of COPD patients
D Makris, T Vrekoussis, M Izoldi, K Alexandra, D Katerina, T Dimitris, ...
Respiratory medicine 103 (8), 1130-1135, 2009
Decreased small airway and alveolar CD83+ dendritic cells in COPD
M Tsoumakidou, AV Koutsopoulos, N Tzanakis, K Dambaki, E Tzortzaki, ...
Chest 136 (3), 726-733, 2009
Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis
EG Tzortzaki, KM Antoniou, MI Zervou, I Lambiri, A Koutsopoulos, ...
Respiratory medicine 101 (8), 1821-1829, 2007
Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients
M Siganaki, AV Koutsopoulos, E Neofytou, E Vlachaki, M Psarrou, ...
Respiratory research 11 (1), 1-8, 2010
Altered surfactant protein-A expression in type II pneumocytes in COPD
EM Vlachaki, AV Koutsopoulos, N Tzanakis, E Neofytou, M Siganaki, ...
Chest 137 (1), 37-45, 2010
Downregulation of lung mitochondrial prohibitin in COPD
N Soulitzis, E Neofytou, M Psarrou, A Anagnostis, N Tavernarakis, ...
Respiratory medicine 106 (7), 954-961, 2012
Microsatellite DNA instability and loss of heterozygosity in bronchial asthma
E Paraskakis, G Sourvinos, F Passam, N Tzanakis, EG Tzortzaki, ...
European Respiratory Journal 22 (6), 951-955, 2003
Biomarkers in COPD
EG Tzortzaki, I Lambiri, E Vlachaki, NM Siafakas
Current medicinal chemistry 14 (9), 1037-1048, 2007
Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study
M Kupczyk, S Haque, PJ Sterk, E Niżankowska-Mogilnicka, A Papi, ...
Thorax 68 (7), 611-618, 2013
C‐reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy
SE Schiza, C Mermigkis, P Panagiotis, I Bouloukaki, E Kallergis, ...
European journal of clinical investigation 40 (11), 968-975, 2010
Expression of FACIT collagens XII and XIV during bleomycin‐induced pulmonary fibrosis in mice
EG Tzortzaki, JA Tischfield, A Sahota, NM Siafakas, MK Gordon, ...
The Anatomical Record Part A: Discoveries in Molecular, Cellular, and …, 2003
CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?
C Mermigkis, I Bouloukaki, D Mermigkis, E Kallergis, E Mavroudi, ...
Sleep and Breathing 16 (3), 813-819, 2012
The system can't perform the operation now. Try again later.
Articles 1–20